Our Expert Speakers

Erik Yusko

Sr. Director, Drug Discovery

Adaptive Biotechnologies

Hans-Peter Gerber

SVP & CSO

3T Biosciences

Leah Sibener

Co-founder, Head of Therapeutic Discovery

3T Biosciences

Rachel Abbott

Senior Director, Head of TCR Pipeline and Dark Antigen Research

Enara Bio

Reagan Jarvis

CEO

Anocca

Reno Debets

Founder & CSO, Professor

Pan Cancer T, Erasmus MC Cancer Institute

Ali Mohamed

VP, CMC

Immatics

Cheng Liu

Founder & CEO

Eureka Therapeutics

David Scheinberg

Chairman, Molecular Pharmacology Program; & Experimental Therapeutics Center

Memorial Sloan Kettering Cancer Center

Dolores Schendel

CEO & CSO

Medigene AG

Mohammed Dar

CMO

Immunocore

Sandra Müller

Scientist Oncology Research

Molecular Partners AG

Erika Von Euw

Director, Translational Research

T-Cure Biosciences Inc

Gang Zeng

CEO

T-Cure Biosciences Inc.

Gavin Macbeath

CSO

TScan Therapeutics

Marcus Butler

Medical Oncologist, Tumor Immunotherapy Program

Princess Margaret Cancer Centre

Paul Lammers

President & CEO

Triumvira Immunologics

Shannon Oda

Assistant Professor

Seattle Children’s Research Institute & University of Washington

Jey Cheng

Senior Research Scientist

Promega

Namir Hassan

CEO

Zelluna Immunotherapy

Raffaele Baffa

CMO

Ziopharm Oncology

Stephen Haley

Vice President AMER and Global Strategic Liaison

Immudex

William Hildebrand

Chief Scientist

Pure MHC

EVENT GUIDE